| Product Name |
Recombinant Human Plasminogen Activator, Urokinase (uPA/PLAU) Protein |
| Product Overview |
This recombinant human Plasminogen Activator, Urokinase (uPA/PLAU) protein includes amino acids 21-179 of the target gene is expressed in E.coli.The protein is supplied in lyophilized form and formulated in PBS pH 7.4, 0.01% SKL, 5% Trehalose, 1% Mannitolprior to lyophilization. |
| Target Uniprot Id |
P00749 |
| Recommended Name |
Urokinase-type plasminogen activator |
| Gene Name |
PLAU |
| Synonyms |
PLAU; ATF; URK; UK; UP-A; Abbokinase; Urokinase-Type Plasminogen Activator |
| Species |
Human |
| Predicted Molecular Mass |
19 kDa |
| Expression System |
E.coli |
| Expression Range |
21-179 |
| Tag |
N-6His |
| Purity |
>90% |
| Formulation |
Lyophilized |
| Buffer |
PBS pH 7.4, 0.01% SKL, 5% Trehalose, 1% Mannitol |
| Storage Condition |
1. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. 2. Avoid repeated freeze-thaw cycles. 3. Store working aliquots at 4°C for up to one week. 4. In general, protein in liquid form is stable for up to 6 months at -20°C/-80°C. Protein in lyophilized powder form is stable for up to 12 months at -20°C/-80°C. |
| Reconstitution Instruction |
Briefly centrifuged the vial prior to opening to bring the contents to the bottom. Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. It is recommended to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. The default final concentration of glycerol is 50%. |
| Applications |
Positive Control; Immunogen; SDS-PAGE; WB |
| Research Area |
Cardiovascular |
| Target Function |
Specifically cleaves the zymogen plasminogen to form the active enzyme plasmin. |
| Subcellular Location |
Secreted. |
| Protein Family |
Peptidase S1 family |
| Associated Diseases |
Quebec platelet disorder (QPD) |
| Tissue Specificity |
Expressed in the prostate gland and prostate cancers. |
